SG Americas Securities’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.38M | Buy |
34,012
+28,789
| +551% | +$1.17M | 0.01% | 865 |
|
|
2025
Q1 | $268K | Buy |
5,223
+2,062
| +65% | +$106K | ﹤0.01% | 2057 |
|
|
2024
Q4 | $175K | Sell |
3,161
-4,081
| -56% | -$226K | ﹤0.01% | 2015 |
|
|
2024
Q3 | $238K | Buy |
7,242
+3,379
| +87% | +$111K | ﹤0.01% | 2085 |
|
|
2024
Q2 | $105K | Sell |
3,863
-6,811
| -64% | -$185K | ﹤0.01% | 2215 |
|
|
2024
Q1 | $388K | Sell |
10,674
-44,305
| -81% | -$1.61M | ﹤0.01% | 1384 |
|
|
2023
Q4 | $1.11M | Buy |
54,979
+4,266
| +8% | +$86.4K | 0.01% | 859 |
|
|
2023
Q3 | $901K | Buy |
50,713
+9,141
| +22% | +$162K | 0.01% | 1256 |
|
|
2023
Q2 | $751K | Buy |
+41,572
| New | +$751K | 0.01% | 1073 |
|
|
2022
Q3 | – | Sell |
-50,512
| Closed | -$737K | – | 3121 |
|
|
2022
Q2 | $737K | Buy |
50,512
+8,073
| +19% | +$118K | 0.01% | 1440 |
|
|
2022
Q1 | $714K | Sell |
42,439
-1,891
| -4% | -$31.8K | 0.01% | 1468 |
|
|
2021
Q4 | $997K | Sell |
44,330
-1,923
| -4% | -$43.2K | 0.01% | 1504 |
|
|
2021
Q3 | $997K | Buy |
46,253
+23,276
| +101% | +$502K | ﹤0.01% | 1752 |
|
|
2021
Q2 | $666K | Buy |
+22,977
| New | +$666K | ﹤0.01% | 1626 |
|